Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWarpaint London Regulatory News (W7L)

Share Price Information for Warpaint London (W7L)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 480.00
Bid: 475.00
Ask: 485.00
Change: 7.50 (1.59%)
Spread: 10.00 (2.105%)
Open: 475.00
High: 480.00
Low: 472.50
Prev. Close: 472.50
W7L Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Full Year Trading Update

1 Feb 2022 07:00

RNS Number : 2266A
Warpaint London PLC
01 February 2022
 

1 February 2022

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

Warpaint London PLC

("Warpaint", the "Company" or the "Group")

 

Full Year Trading Update

 

Strong 2021 trading and results expected to be ahead of market expectations

 

Warpaint London plc (AIM: W7L), the specialist supplier of colour cosmetics and owner of the W7 and Technic brands is pleased to announce an update on trading for the year ended 31 December 2021.

 

The Company announced in its trading update on 2 November 2021, sales for the year ending 31 December 2021 were expected to be similar to those achieved in 2019 (2020: £40.3 million, 2019: £49.3 million), the most recent financial year that experienced no impact from the Covid-19 pandemic. Following completion of the year, the Company is now pleased to report that unaudited sales for the year ended 31 December 2021 have exceeded those achieved in 2019 at £50 million.

 

Gross margins for the year ended 31 December 2021 were maintained ahead of those achieved in 2020 and 2019 at approximately 33.8% (2020: 31.1%, 2019: 33.5%), despite increased costs in the supply chain, particularly in respect of freight.

 

For the year ended 31 December 2021, subject to audit, the Group's Adjusted EBITDA*is expected to be approximately £7.7 million (2020: £4.2 million, 2019: £7.0 million) and Adjusted Profit Before Tax** (2020: £2.3 million, 2019: £5.2 million) is expected to be approximately £6.6 million, both of which are ahead of market expectations.

 

The Company's cash balances as at 31 December 2021 totalled £4.1 million (31 December 2020: £4.9 million) and the Company had no debt, after significant stock purchases to satisfy anticipated Q1 2022 demand.

 

The Group expects to release its results for the year ended 31 December 2021 in April 2022.

 

* Adjusted for foreign exchange movements, share based payments and exceptional items.

** Adjusted for exceptional costs, amortisation of intangible assets, and share based payments. Adjusted numbers are close to the underlying cash flow performance of the business which is regularly monitored and measured by management.

 

Commenting, Sam Bazini Chief Executive, said: "I am pleased to report that we ended 2021 ahead of current market expectations. In 2021 we enjoyed particularly strong sales growth in the UK, significant growth internationally and further increases in online sales. It was pleasing that we were able to maintain our margins at pre-pandemic levels, despite some inflationary headwinds, particularly with freight costs.

 

"We expect to see a continuing improvement in performance in 2022 and have started the year strongly. In line with our stated strategy we have significant opportunities for further growth, both with our existing retailers, and those such as Boots where we are expecting to launch very shortly, together with others that we are in discussions with. I look forward to providing further updates at the time of the release of the Group's results in April."

 

Enquiries:

Warpaint London

c/o IFC

Sam Bazini - Chief Executive Officer

Eoin Macleod - Managing Director

Neil Rodol - Chief Finance Officer

Singer Capital Markets (Nominated Adviser & Joint Broker)

020 7496 3000

Shaun Dobson, Tom Salvesen, Jen Boorer, Alex Bond - Investment Banking

Shore Capital (Joint Broker)

020 7408 4090

Patrick Castle, Daniel Bush - Corporate Advisory

Fiona Conroy - Corporate Broking

 

IFC Advisory (Financial PR & IR)

020 3934 6630

Tim Metcalfe

Graham Herring

Florence Chandler

 

Warpaint London plc

 

Warpaint sells branded cosmetics under the lead brand names of W7 and Technic. W7 is sold in the UK primarily to retailers and internationally to local distributors or retail chains. The Technic brand is sold in the UK and continental Europe with a significant focus on the gifting market, principally for high street retailers and supermarkets. In addition, Warpaint supplies own brand white label cosmetics produced for several major high street retailers. The Group also sells cosmetics using its other brand names of Man'stuff, Body Collection, Very Vegan, and Chit Chat.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSDLFUFEESEFF
Date   Source Headline
29th Apr 20247:37 amRNSHolding(s) in Company
24th Apr 20247:00 amRNSResults for the year ended 31 December 2023
9th Apr 20247:00 amRNSBlock listing Interim Return
9th Apr 20247:00 amRNSTrading Update and Notice of Results
26th Mar 20242:37 pmRNSHolding(s) in Company
1st Feb 20247:00 amRNSWard & Hagon Contract Renewal
12th Jan 20247:00 amRNSTrading Update
12th Dec 20237:00 amRNSAppointment of Non-Executive Directors
1st Dec 20233:37 pmRNSTotal Voting Rights
24th Nov 20237:00 amRNSGrant of Options
21st Nov 202311:23 amRNSPDMR Dealing
20th Nov 20231:24 pmRNSHolding(s) in Company
10th Nov 20237:00 amRNSTrading Update
9th Nov 20237:00 amRNSBlock Listing Interim Return
31st Oct 20237:00 amRNSTotal Voting Rights
13th Oct 20233:38 pmRNSHolding(s) in Company
4th Oct 20237:00 amRNSHolding(s) in Company
3rd Oct 20233:26 pmRNSHolding(s) in Company
3rd Oct 202312:25 pmRNSBlocklisting Application
28th Sep 20235:47 pmRNSHolding(s) in Company
20th Sep 20237:00 amRNSInterim Results
19th Sep 20233:51 pmRNSHolding(s) in Company
12th Sep 20237:00 amRNSNotice of Results
22nd Aug 202312:31 pmRNSHolding(s) in Company
27th Jul 20234:34 pmRNSHolding(s) in Company
3rd Jul 20237:00 amRNSTotal Voting Rights
28th Jun 20231:40 pmRNSResult of AGM
28th Jun 20237:00 amRNSAGM Statement
15th Jun 20237:00 amRNSTrading Update
6th Jun 20237:00 amRNSPDMR Dealings
24th May 20237:00 amRNSNotice of AGM and Posting of Annual Report
9th May 202311:28 amRNSHolding(s) in Company
2nd May 20234:31 pmRNSBlocklisting Application
26th Apr 20237:00 amRNSResults for the year ended 31 December 2022
24th Mar 20237:00 amRNSTrading Update and Notice of Results
14th Feb 202310:16 amRNSAIM Rule 17 Notification
11th Jan 20237:00 amRNSFull Year Trading Update
3rd Jan 20237:00 amRNSResignation of Non-Executive Director
14th Oct 20227:00 amRNSRenewal of New Moorcroft House lease at Silsden
21st Sep 20227:00 amRNSInterim Results
16th Sep 20227:00 amRNSChange of Adviser
8th Sep 20224:40 pmRNSSecond Price Monitoring Extn
8th Sep 20224:36 pmRNSPrice Monitoring Extension
8th Sep 20222:06 pmRNSSecond Price Monitoring Extn
8th Sep 20222:00 pmRNSPrice Monitoring Extension
8th Sep 202211:05 amRNSSecond Price Monitoring Extn
8th Sep 202211:00 amRNSPrice Monitoring Extension
8th Sep 20227:00 amRNSTrading Update
1st Sep 20227:00 amRNSNotice of Results and Investor Webinar
29th Jun 20227:00 amRNSPMDR / PCA Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.